There are 2789 resources available
1686P - Selecting patient-reported outcomes to monitor symptomatic toxicities of immune-checkpoint inhibitors: A Delphi study
Presenter: André Lopes
Session: ePoster Display
1687P - Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomized controlled trials: A systematic review and meta-analysis
Presenter: Andrea Boutros
Session: ePoster Display
1688P - Impact of immunotherapy on the risk of thromboembolic disease in patients with melanoma
Presenter: David Fernandez Garay
Session: ePoster Display
1689P - Adverse event management during treatment with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1: Treatment guidelines based on experience in clinical trials
Presenter: James Gulley
Session: ePoster Display
1690P - A multicenter randomized phase II open label study to compare the safety and efficacy of direct oral anticoagulants versus subcutaneous dalteparin for cancer-associated venous thromboembolism in patients with advanced upper gastrointestinal, hepatobiliary and pancreatic cancer
Presenter: Jwa Hoon Kim
Session: ePoster Display
1691P - Thromboembolic disease and immunotherapy in lung cancer
Presenter: David Fernandez Garay
Session: ePoster Display
1692P - Thromboprophylaxis in high-risk oncology patients: Is it a safe and effective clinical decision-intervention?
Presenter: Nikolaos Tsoukalas
Session: ePoster Display
1693P - Efficacy of corticosteroids in the treatment of chemotherapy-induced thrombocytopenia
Presenter: Andrea Sbrana
Session: ePoster Display
1694P - Coffee and tea consumption (CTC), patient-reported (PRO), and clinical outcomes in a longitudinal study of patients (pts) with breast cancer (BC)
Presenter: Davide Soldato
Session: ePoster Display
1695P - ePRO follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care
Presenter: Sanna Iivanainen
Session: ePoster Display